Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  British American Tobacco    BATS   GB0002875804

My previous session
Most popular
Analysis summaryMarketScreener Strategies

Anticipation of a bearish reversal

share with twitter share with LinkedIn share with facebook
share via e-mail
01/23/2015 | 10:03am

British American Tobacco should undergo some profit-taking after the rebound in recent sessions.

From a fundamental viewpoint, the company could suffer from downward EPS revisions from analysts. Indeed, this situation could lead the stock to more pronounce profit taking.

After a substantial upturn, the stock now approaches the resistance at GBp 3794.5, fact that could inverse the tendency. In addition, a high RSI indicator should entice a marked fall close to the short term GBp 3554 support. Moreover, in daily data, shares have just feed a double bottom pattern which could act as an additional argument for some profit taking.

The graphical configuration argues to establish a short position at the current price. The end of the technical rebound, the consolidation phase and overbought situation: British American Tobacco has all the characteristics for short selling. The first objective will be fixed near the GBp 3554 short term support. This strategy should be protected by a stop loss above GBp 3794.5.

Pierre Gilles de la Londe
© Zonebourse.com 2015
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (GBP)
Sales 2018 24 538 M
EBIT 2018 10 398 M
Net income 2018 6 287 M
Debt 2018 44 078 M
Yield 2018 5,55%
P/E ratio 2018 12,35
P/E ratio 2019 11,13
EV / Sales 2018 5,12x
EV / Sales 2019 4,80x
Capitalization 81 657 M
Surperformance© ratings
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
Duration : Period : Day
British American Tobacco Technical Analysis Chart | MarketScreener
Duration : Period : Week
British American Tobacco Technical Analysis Chart | MarketScreener